# A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth

> **NCT03911414** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 27 (actual)

## Conditions studied

- Mood Disturbance
- Mood Disorders
- Natural Supplements
- Alternative Treatment

## Interventions

- **DRUG:** Open-label Treatment with Omega-3 Fatty Acids + Inositol
- **DRUG:** Open-label Treatment with N-acetylcysteine

## Key facts

- **NCT ID:** NCT03911414
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-18
- **Primary completion:** 2024-12-04
- **Final completion:** 2024-12-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03911414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03911414, "A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03911414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*